Austrian Breast and Colorectal Cancer Group   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Vienna Austria (1984)

Organization Overview

First Clinical Trial
1990
NCT00309530
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Austrian Breast and Colorectal Cancer Study Group | Austrian Breast & Colorectal Cancer Study Group (ABCSG)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Carcinoma (Phase 2)

Colonic Neoplasms (Phase 3)

Colorectal Neoplasms (Phase 2)

Fatty Liver (Phase 2)

Rectal Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 21
  • # of Trial APIs: 25